1Yoshio G,Takenori O,Shimada H,et al.Gene therapy for cancer[J].Surg Today,2000,30:967～963.
2Colombo F,Barzon L,Franchin E,et al.Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme:biological and clinical results[J].Cancer Gene Ther,2005,12(10):835～848.
3Kubo H,Gardner TA,Wada Y,et al.Phase I dose escalatin clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancer[J].Hum Gene Ther,2003,10,14(3):227～41.
4Freeman SM, Ramesh R, Munshi A,et al.Tumor killing using the HSV-tk suicide gene[J].Cancer Gene Therapy, 1996,3 :S30.
5Kunishige I, Samejima Y, Moriyama A, et al.cAMP stimulates the bystander effect in suicide gene therapy of human choriocarcinoma[J].Anticancer Res, 1998,18:3411.
